Advertisement
Screener

PASITHEA THERAPEUTICS CORP. (KTTA) Gain (Loss) Related to Litigation Settlement

1.8 / 5 stars · 12/33 Roast Me

PASITHEA THERAPEUTICS CORP. Gain (Loss) Related to Litigation Settlement

PASITHEA THERAPEUTICS CORP. (KTTA) reported Gain (Loss) Related to Litigation Settlement of -$1.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.

Discontinued › Income Statement › Other Income

us-gaap:GainLossRelatedToLitigationSettlement · last filed 2024-03-29

  • PASITHEA THERAPEUTICS CORP. gain (loss) related to litigation settlement for fiscal 2022 was -$1.00M.
Period endGain (Loss) Related to Litigation Settlement 12 monthGain (Loss) Related to Litigation Settlement 12 month as first filed
2022-12-31-$1.00M
10-K · filed 2024-03-29
-$1.02M
10-K · filed 2023-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Lipocine Inc. (LPCN)United States$0.017B-1.79
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Rocket One Inc. (RKTO)United States$0.019B